Amgen (AMGN) announced a $900M expansion of its Ohio manufacturing facility, bringing the total number of jobs created to 750 and the total ...

Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number of jobs created to 750 and the total investment in Central Ohio to over $1.4 ...

Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight.Stay Ahead of the Market: Discover outperforming stocks and invest ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" highlights the details around ENTYVIO, a gut-selective ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...

Amgen When Dr. David Reese, Amgen’s first chief technology officer, set about hiring a head of artificial intelligence last year, he looked at people who’d worked in consumer products, finance ...

First Global Phase 3 Trial Showing Substantial ... Research and Development, at Amgen. "We look forward to sharing these results with the scientific community and health authorities as we ...

Amgen has gotten caught up in the broader market decline, but its business is unscathed. Its obesity drug sales are about to boom, making the stock look like a buy.

Stocks like Pfizer, Amgen, Johnson & Johnson, and Eli Lilly & Co. were among others which opened lower after the US stock market opened on Wednesday. Pfizer Inc. shares are currently trading 2.56 ...